Department of Internal Medicine, Yale-New Haven Hospital-Waterbury Hospital, Waterbury, Connecticut.
Departments of Ophthalmology and Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania.
Ophthalmology. 2015 Mar;122(3):595-9. doi: 10.1016/j.ophtha.2014.09.039. Epub 2014 Nov 20.
To compare ingredients contained in top-selling brands of ocular nutritional supplements with the Age-Related Eye Disease Study (AREDS) and AREDS2 formulae and investigate the validity of claims made by manufacturers of leading brands of ocular nutritional supplements.
Descriptive.
None.
We examined the 5 top-selling brands of ocular nutritional supplements in the United States according to dollar sales tracked by SymphonyIRI (Waltham, MA) from June 2011 to June 2012. We reviewed the ingredients and manufacturer claims of 11 ocular nutritional supplements on the companies' consumer information websites; the ingredients were compared with those contained in the AREDS and AREDS2 formulae.
Proportion of ocular nutritional supplements that contained the same ingredients, in the same doses, as the AREDS or AREDS2 formula; proportion of nutritional supplements with unsubstantiated claims made by the manufacturer.
All of the ocular nutritional supplements contained the ingredients from the AREDS or AREDS2 formula; 36% (4/11) of the supplements contained equivalent doses of AREDS or AREDS2 ingredients; 55% (6/11) included some information about the AREDS on their consumer information websites. Product descriptions from 4 of the 11 supplements (36%) stated that the supplements were important to maintain general eye health; none of these supplements duplicated the AREDS or AREDS2 formula. All the individual supplements claimed to "support," "protect," "help," or "promote" vision and eye health, but none specified that there is no proven benefit in using nutritional supplements for primary prevention of eye disease.
The majority of top-selling ocular nutritional supplements did not contain the identical ingredient dosages of the AREDS or AREDS2 formula and had product description claims that lacked level 1 evidence, underscoring the importance of ophthalmologists educating their patients on the evidence-based role of nutritional supplements in the management of eye health.
比较畅销的眼部营养补充剂品牌所含成分与《年龄相关性眼病研究》(AREDS)和 AREDS2 配方,并调查领先品牌眼部营养补充剂制造商声称的有效性。
描述性研究。
无。
我们根据 SymphonyIRI(马萨诸塞州沃尔瑟姆)在 2011 年 6 月至 2012 年 6 月期间跟踪的美元销售额,检查了美国销量最高的 5 种眼部营养补充剂品牌。我们查看了 11 种眼部营养补充剂在公司消费者信息网站上的成分和制造商声称;将这些成分与 AREDS 和 AREDS2 配方中的成分进行比较。
含有与 AREDS 或 AREDS2 配方相同成分且剂量相同的眼部营养补充剂的比例;制造商声称未经证实的营养补充剂的比例。
所有的眼部营养补充剂都含有 AREDS 或 AREDS2 配方中的成分;36%(4/11)的补充剂含有与 AREDS 或 AREDS2 成分等效的剂量;11 种补充剂中有 55%(6/11)在其消费者信息网站上包含了一些关于 AREDS 的信息。11 种补充剂中的 4 种(36%)的产品说明指出,补充剂对维持一般眼部健康很重要;这些补充剂都没有复制 AREDS 或 AREDS2 配方。所有的单个补充剂都声称“支持”、“保护”、“帮助”或“促进”视力和眼部健康,但都没有具体说明使用营养补充剂对眼病的一级预防没有益处。
大多数畅销的眼部营养补充剂并不含有与 AREDS 或 AREDS2 配方相同的成分剂量,并且其产品说明声称缺乏一级证据,这突显了眼科医生向患者传授营养补充剂在眼部健康管理中的循证作用的重要性。